ProQR Therapeutics (PRQR) Revenue (2012 - 2026)
ProQR Therapeutics (PRQR) posted quarterly Revenue of $2.3 million for Q1 2026, down 55.01% year-on-year from $5.1 million in Q1 2025, and down 56.63% on a QoQ basis from $5.3 million in Q4 2025.
ProQR Therapeutics (PRQR) Revenue (2012 - 2026) Analysis & Trends
ProQR Therapeutics (PRQR) has reported Revenue for 15 consecutive years, with $2.3 million the latest figure, recorded in Q1 2026.
- Quarterly Revenue fell 55.01% year-over-year to $2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.3 million (down 29.27% YoY) and the FY2025 annual result came in at $18.1 million, down 15.86% from the prior year.
- Revenue declined to $2.3 million in Q1 2026 per PRQR's latest filing, from $5.3 million in the prior quarter.
- Over the last five years, Revenue for PRQR reached as high as $7.2 million in Q2 2024 and fell as low as $745360.0 in Q1 2023.
- A 5-year average of $3.1 million and a median of $3.3 million in 2025 frame the typical range for Revenue.
- Annual changes were most pronounced in 2022 — Revenue sank 90.66% — and 2024, when it soared 579.39%.
- Year by year, Revenue stood at $819327.1 in 2022, then jumped by 356.11% to $3.7 million in 2023, then soared by 31.15% to $4.9 million in 2024, then climbed by 8.85% to $5.3 million in 2025, then sank by 56.63% to $2.3 million in 2026.
- According to Business Quant data, Revenue over the past three periods registered $2.3 million, $5.3 million, and $3.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.51 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.56 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | ProQR Therapeutics | 219.53 Mn | 175.72 Mn | - | 2.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.31 Mn |
| Dec 31, 2025 | 5.33 Mn |
| Sep 30, 2025 | 3.28 Mn |
| Jun 30, 2025 | 4.34 Mn |
| Mar 31, 2025 | 5.14 Mn |
| Dec 31, 2024 | 4.90 Mn |
| Sep 30, 2024 | 4.37 Mn |
| Jun 30, 2024 | 7.17 Mn |
| Mar 31, 2024 | 5.06 Mn |
| Dec 31, 2023 | 3.74 Mn |
| Sep 30, 2023 | 1.56 Mn |
| Jun 30, 2023 | 1.37 Mn |
| Mar 31, 2023 | 745,360.05 |
| Dec 31, 2022 | 819,327.08 |
| Sep 30, 2022 | 926,294.78 |
| Jun 30, 2022 | 1.06 Mn |
| Mar 31, 2022 | 1.29 Mn |
| Dec 31, 2021 | 271,971.07 |
| Sep 30, 2021 | 992,296.12 |
| Jun 30, 2021 | 276,522.89 |